First Wave BioPharma, Inc. (FWBI)
NASDAQ: FWBI · IEX Real-Time Price · USD
3.950
-0.020 (-0.50%)
At close: Mar 27, 2024, 4:00 PM
3.900
-0.050 (-1.27%)
After-hours: Mar 27, 2024, 7:38 PM EDT

First Wave BioPharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202220212020201920182017201620152014
Net Income
-14.97-84.52-41.73-15.18-13.53-11.1-14.59-5.93-2.37
Depreciation & Amortization
0.030.540.561.020.80.750.730.730.43
Share-Based Compensation
0.771.370.551.182.481.10.600
Other Operating Activities
-8.5124.3420.34-1.06-0.612.068.721.030.93
Operating Cash Flow
-22.34-32.29-11.22-14.03-10.87-7.18-4.53-4.17-1.01
Capital Expenditures
0-0.070.09-0.02-0.06-0.03-0.01-0.02-0.19
Acquisitions
0000-0.25000-0.56
Other Investing Activities
--10.25-------
Investing Cash Flow
0-10.320.09-0.02-0.31-0.03-0.01-0.02-0.75
Share Issuance / Repurchase
23.137.570.999.4811.95.015.2800.86
Debt Issued / Paid
-0.640.092.863.61-0.1911.895.020.99
Other Financing Activities
-6.727.1113.20.06---1.42-0.34-
Financing Cash Flow
15.7444.7617.0513.1411.716.015.754.681.85
Exchange Rate Effect
-0.260.03-0.03-0.0300-0.0100
Net Cash Flow
-6.62.165.91-0.910.54-1.21.20.490.09
Free Cash Flow
-22.34-32.36-11.13-14.06-10.92-7.22-4.55-4.19-1.2
Free Cash Flow Per Share
-622.18-15226.08-16445.22-26328.25-29719.32-28517.60-29360.73-48572.05-14201.09
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).